REGN vs TECH — Key Metrics
| Metric | REGN (REGENERON PHARMACEUTICALS INC) | TECH (BIO-TECHNE CORP) |
|---|---|---|
| Price | 758.27 | 72.47 |
| Market Cap | 78.07 Billion | 11.36 Billion |
| P/E (TTM) | 18.08 | 61.94 |
| P/B (Quarterly) | 2.397 | 5.385 |
| P/S (TTM) | 5.03 | 9.35 |
| Net Profit Margin (TTM) | 27.9 | 15.0 |
| Gross Margin (TTM) | 84.9 | 65.8 |
| ROE (TTM) | 13.8 | 8.9 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
REGN · REGENERON PHARMACEUTICALS INC
Greatly Outperform
TECH · BIO-TECHNE CORP
Greatly Underperform
Recommendation Summary
Stock REGN is projected to greatly outperform the market, stock TECH is projected to greatly underperform the market. Upfront Recommendation: REGN.
Financial Metrics
Prices delayed ~15 min
| REGN | Metrics | TECH |
|---|---|---|
| $758.27 | Price | $72.47 |
| — | Market Capitalization | — |
| 18.08 | Price to Earnings Ratio | 61.94 |
| 5.03 | Price to Sales | 9.35 |
| 20.76 | Price to FCF Ratio | 43.17 |
| 5.92 | Price to Gross Profit | 14.22 |
| 12.44 | Price to R&D | 119.92 |
| 4.23 | Price to Current Assets | 15.27 |